A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
Clinical trial NCT05199688 · RECRUITING
Trial details
- NCT number
- NCT05199688
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-06
- Primary completion
- 2027-03-31
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.